AbbVie (ABBV) and the PGA Tour have announced a landmark partnership, naming the pharmaceutical giant the Official Pharmaceutical Sponsor of the PGA Tour and the 2026 Presidents Cup. The centrepiece of the
More
The entertainment industry regularly grapples with decisions about when to seek trademark clearance, even when the law does not strictly demand it. Productions frequently feature branded products, logos, and company names as
More
General Counsel Crystal S. Carey of the National Labor Relations Board has issued Memorandum GC 26-04, signalling a firm and expansive enforcement agenda for the months ahead. Released on August 26, 2026,
More
England is home to the world’s oldest continuously operating law firm, a distinction officially recognised by Guinness World Records. The firm dates back to 1570, predating many of the world’s most established
More
The Supreme Court has refused to lift a judicial block on a controversial US Postal Service rule that critics said would suppress mail-in voting in the 2026 elections. The court issued an
More
The FTSE 100 ended Tuesday’s session in the red, dragged down by soaring bond yields, elevated oil prices, and mounting fears over persistent inflation. London’s benchmark index closed down 39.44 points, or
More
At the recent BRICS Summit, bloc leaders reaffirmed their desire to reduce dependence on the U.S. dollar by expanding trade in local currencies. The push is driven by geopolitical tensions, economic sanctions,
More
Trustpilot (TRST) has reported solid revenue growth, but accounting irregularities have overshadowed what would otherwise have been a positive financial update for the company. The review platform, which allows consumers to rate
More
The weekend’s horse racing calendar is packed with top-level action, with two of Britain’s most prestigious meetings taking centre stage over the coming days. Tom Marriott and Bill Esdaile are back to
More
BioMarin Pharmaceutical has announced it is discontinuing development of Voxzogo for children with Noonan syndrome, marking another setback for the drug’s expansion ambitions. The company said the decision followed an assessment of
More